FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

SASSINE ANDY
2. Issuer Name and Ticker or Trading Symbol

ICAD INC [ icad ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

C/O ICAD, INC., 98 SPIT BROOK ROAD, SUITE 100
3. Date of Earliest Transaction (MM/DD/YYYY)

9/30/2019
(Street)

NASHUA, NH 03062
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Director Stock Option (right to buy)  $6.85  9/30/2019    A     5458      9/30/2019 (1) 9/30/2024  Common Stock  5458  $0  5458  D   

Explanation of Responses:
(1)  The options are exercisable commencing on the Date of Grant.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
SASSINE ANDY
C/O ICAD, INC.
98 SPIT BROOK ROAD, SUITE 100
NASHUA, NH 03062
X



Signatures
/s/Annette Heroux, Attorney-in-Fact 10/2/2019
**Signature of Reporting Person Date


Icad (NASDAQ:ICAD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Icad Charts.
Icad (NASDAQ:ICAD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Icad Charts.

Icad Inc News

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
Thursday 11 April 2024 (2 weeks ago) • GlobeNewswire Inc.
iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation
Tuesday 9 April 2024 (3 weeks ago) • GlobeNewswire Inc.
iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
Monday 8 April 2024 (3 weeks ago) • GlobeNewswire Inc.
iCAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)
Wednesday 3 April 2024 (3 weeks ago) • GlobeNewswire Inc.
iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
Tuesday 2 April 2024 (4 weeks ago) • GlobeNewswire Inc.
iCAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists
Tuesday 19 March 2024 (1 month ago) • GlobeNewswire Inc.
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.
iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings
Wednesday 28 February 2024 (2 months ago) • GlobeNewswire Inc.
iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
Tuesday 27 February 2024 (2 months ago) • GlobeNewswire Inc.
Form 8-K - Current report
Monday 26 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 February 2024 (2 months ago) • Edgar (US Regulatory)